Overview

HU007 in Patients With Dry Eye Syndrome

Status:
Not yet recruiting

Trial end date:
2024-03-01

Target enrollment:

Participant gender:

Summary

A multicenter, Randomized, Double blind, Restasis®-controlled Non-inferiority, Moisview® Eye Drops Controlled Superiority, Phase III Study to Evaluate the Efficacy and Safety of HU007 Eye Drops in Patients with Dry Eye Syndrome

Phase:

Phase 3

Details

Lead Sponsor:

Huons Co., Ltd.

Treatments:

Ophthalmic Solutions